Two Sigma Advisers Portfolio holdings
AUM
$48.8B
1-Year Return
29.82%
This Quarter Return
+8.85%
1 Year Return
+29.82%
3 Year Return
+107.12%
5 Year Return
+201.81%
10 Year Return
+492.86%
AUM
$35.8B
AUM Growth
+$1.27B
(+3.7%)
Cap. Flow
-$1.22B
Cap. Flow
% of AUM
-3.42%
Top 10 Holdings %
Top 10 Hldgs %
13.63%
Holding
2,806
New
288
Increased
941
Reduced
1,237
Closed
311
Top Buys
| 1 |
Amazon
AMZN
|
+$479M |
| 2 |
McDonald's
MCD
|
+$356M |
| 3 |
Advanced Micro Devices
AMD
|
+$248M |
| 4 |
CME Group
CME
|
+$229M |
| 5 |
PayPal
PYPL
|
+$222M |
Top Sells
| 1 |
JPMorgan Chase
JPM
|
+$514M |
| 2 |
Meta Platforms (Facebook)
META
|
+$261M |
| 3 |
Merck
MRK
|
+$235M |
| 4 |
Microsoft
MSFT
|
+$212M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$191M |
Sector Composition
| 1 | Technology | 24.74% |
| 2 | Healthcare | 17.85% |
| 3 | Industrials | 11.5% |
| 4 | Financials | 11.16% |
| 5 | Consumer Discretionary | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Nature's Sunshine
NATR
$302M
| $339K | ﹤0.01% |
40,800
-8,800
| -18% | -$73.2K |
|
2027
Stoke Therapeutics
STOK
$1.24B
| $338K | ﹤0.01% |
36,600
+11,000
| +43% | +$102K |
|
2028
TTM Technologies
TTMI
$5.11B
| $336K | ﹤0.01% |
22,300
+300
| +1% | +$4.52K |
|
2029
Fabrinet
FN
$13.3B
| $333K | ﹤0.01% |
2,600
-21,500
| -89% | -$2.76M |
|
|
TBI
2030
Trueblue
TBI
$171M
| $333K | ﹤0.01% |
+17,000
| New | +$333K |
|
2031
Simulations Plus
SLP
$280M
| $333K | ﹤0.01% |
9,100
+3,300
| +57% | +$121K |
|
2032
GCM Grosvenor
GCMG
$681M
| $333K | ﹤0.01% |
43,700
-3,100
| -7% | -$23.6K |
|
2033
Utah Medical Products
UTMD
$195M
| $332K | ﹤0.01% |
3,300
| – | – |
|
2034
FirstEnergy
FE
$25B
| $331K | ﹤0.01% |
7,900
-401,300
| -98% | -$16.8M |
|
2035
Full House Resorts
FLL
$120M
| $331K | ﹤0.01% |
44,000
-21,100
| -32% | -$159K |
|
2036
Babcock & Wilcox
BW
$266M
| $330K | ﹤0.01% |
57,227
-44,000
| -43% | -$254K |
|
2037
USCB Financial Holdings
USCB
$349M
| $329K | ﹤0.01% |
+27,000
| New | +$329K |
|
2038
Oric Pharmaceuticals
ORIC
$1.02B
| $328K | ﹤0.01% |
55,700
-112,586
| -67% | -$663K |
|
2039
Agnico Eagle Mines
AEM
$76.8B
| $328K | ﹤0.01% |
6,309
-43,691
| -87% | -$2.27M |
|
2040
Oportun Financial
OPRT
$283M
| $323K | ﹤0.01% |
58,700
-18,000
| -23% | -$99.2K |
|
2041
Y-mAbs Therapeutics
YMAB
$390M
| $323K | ﹤0.01% |
+66,100
| New | +$323K |
|
|
SLGC
2042
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $322K | ﹤0.01% |
128,300
+41,600
| +48% | +$104K |
|
2043
Inseego
INSG
$199M
| $322K | ﹤0.01% |
38,220
-13,060
| -25% | -$110K |
|
|
OGI
2044
Organigram Holdings
OGI
$221M
| $322K | ﹤0.01% |
100,518
-15,375
| -13% | -$49.2K |
|
2045
Marcus Corp
MCS
$485M
| $321K | ﹤0.01% |
22,300
-42,738
| -66% | -$615K |
|
2046
Home Bancorp
HBCP
$437M
| $320K | ﹤0.01% |
8,000
-3,800
| -32% | -$152K |
|
2047
Mohawk Industries
MHK
$8.41B
| $319K | ﹤0.01% |
+3,124
| New | +$319K |
|
2048
Townsquare Media
TSQ
$115M
| $319K | ﹤0.01% |
44,000
-12,700
| -22% | -$92.1K |
|
2049
Comscore
SCOR
$31.6M
| $319K | ﹤0.01% |
13,745
-6,875
| -33% | -$160K |
|
2050
Warby Parker
WRBY
$3.29B
| $318K | ﹤0.01% |
+23,600
| New | +$318K |
|